期刊文献+

甲状腺乳头状微小癌侧颈淋巴结转移分析 被引量:2

Clinical Analysis of Lateral Cervical Lymph Node Metastases from Papillary Thyroid Microcarcinoma
下载PDF
导出
摘要 目的:分析伴侧颈淋巴结(Ⅱ~Ⅴ区)转移的甲状腺乳头状微小癌(PTMC)的临床生物学特性及预后,探讨侧颈淋巴结转移的危险因素及合适的治疗方案。方法:回顾性分析2001年8月至2006年8月天津医科大学附属肿瘤医院收治的具有完整病例资料的PTMC 286例,其中病理证实存在Ⅱ-Ⅴ区淋巴结转移者35例,并通过SPSS 17.0软件进行统计分析。结果:本组病例男女比例为1:2.9,平均年龄45.7岁。18例(51.4%)患者以侧颈部肿物就诊。14例(40.0%)患者伴发桥本氏甲状腺炎。10例(28.6%)原发灶侵出甲状腺腺叶。多灶性(40.0%)及癌灶位于甲状腺上极的比例(54.3%)均高于同期不伴侧颈淋巴结转移的PTMC(P<0.05)。1例患者就诊时发现肺转移。侧颈淋巴结转移Ⅳ区最常见,其次为Ⅲ区、Ⅱ区,Ⅴ区最少见。11例患者Ⅵ区未见转移而侧颈出现淋巴结转移。随访发现1例患侧颈部淋巴结复发,2例对侧颈部出现淋巴结转移,1例肺转移,1例患侧颈部淋巴结复发且对侧甲状腺发现新发癌灶。结论:此类患者多数以颈部肿物就诊,因甲状腺原发灶隐匿,容易误诊。与同期不伴侧颈淋巴结转移PTMC者性别、年龄、伴发桥本氏甲状腺炎及腺外侵犯率差异不明显。多灶性及癌灶位于甲状腺上极可能是PTMC出现侧颈淋巴结转移的危险因素。此类患者复发率高,应采取积极的治疗方案,并应加强随访力度。 Objective: To analyze the clinical biological characteristics and prognosis of papillary thyroid microcarcinoma and to investigate the treatment and risk factors of lateral cervical lymph node metastases from papillary thyroid microearcinoma. Methods: A total of 286 patients with papillary thyroid microcarcinoma, who were treated in Tianjin Medical University Cancer Institute and Hospital between August 2001 and August 2006, were retrospectively studied. Cases, which had lateral cervical lymph node metastases as confirmed by pathology, were chosen. Clinical data was then evaluated using SPSS 17.0 statistical software package. Results: The ratio of male to female was 1:2.9, and the mean age was 45.7 years. Of the 35 patients, 18 ( 51.4% ) patients came to the hospital because of lateral cervical mass. Fourteen ( 40.0% ) patients also had Hashimoto's thyroiditis, whereas 10 ( 28.6% ) patients were extrathyroidal or had invasion into the surrounding tissue or organs. Fourteen ( 40.0% ) patients had multifocality, and carcinomas occupied the upper re- gion of the thyroid in 55.6% patients, which were both higher than the rate in papillary thyroid microcarcinoma without lateral cervical lymph node metastases ( P 〈 0.05 ). Moreover, one patient also had distant metastasis. Lateral cervical lymph node metastases in com- partment IV were most common, while they were rare in compartment V. There were 11 patients whose lymph nodes in compartment VI appeared negative, but their lateral cervical compartments were positive. Follow-up data were as follows: one patient relapsed into primary lateral cervical compartments; two patients had new lymph node metastases in contralateral neck; one patient had distant metas- tases; one patient relapsed in primary lateral cervical compartments and found new carcinoma in remnant thyroid. Conclusion: In pa- tients with lateral cervical mass, the diagnosis of lymph node metastasis from papillary thyroid microcarcinoma should be always con- sidered. The ratio of male to female, the mean age, and the rate of coexisting Hashimoto's thyroiditis and extrathyroidal invasion did not differ significantly from papillary thyroid microcarcinoma without lateral cervical lymph node metastases. Multifocality and carcinomas occupying the upper region of the thyroid may be the risk factors of lateral cervical lymph node metastases from papillary thyroid microcarcinoma. Prognosis is relatively poor, and the disease can recur easily. Thus, positive treatment should be chosen, and long-term follow-up is necessary.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2011年第24期1588-1590,1593,共4页 Chinese Journal of Clinical Oncology
关键词 甲状腺乳头状微小癌 侧颈淋巴结转移 桥本氏甲状腺炎 多发病灶 Papillary thyroid microcarcinoma Lateral cervical lymph node metastases Hashimoto's thyroiditis Multifocality
  • 相关文献

参考文献9

  • 1李小龙,高明,郑向前,于洋.甲状腺乳头状微小癌的临床生物学特性研究[J].中国肿瘤临床,2008,35(23):1325-1327. 被引量:10
  • 2Sakorafas GH,Giotakis J,Stafyla V.Papillary thyroid microcardnoma:a surgical perspective[J].Cancer Treat Rev,2005,31(6):423-438.
  • 3Garrel R,Tripodi C,CartierC,et al.Cervical lymphadenopathies signaling thyroid microcarcinoma.Case study and review of the literature[J].Eur Ann Otorhinolaryngol Head Neck Dis,2011,128(3):115-119.
  • 4Seven H,Gurkan A,Cinar U,et al.Incidence of occult thyroid carcinoma metastases in lateral cervical cysts[J].Am J Otolaryngol,2004,25(1):11-17.
  • 5林琳,郑向前,刘磊,李亦工,张艳,高明.多灶性甲状腺乳头状癌的生物学特性及治疗分析[J].中华普通外科杂志,2010,25(8):621-623. 被引量:24
  • 6Ito Y,Tomoda C,Uruno T,et al.Papillary microcarcinoma of the thyroid:how should it be treated[J].World J Surg,2004,28(11):1115-1121.
  • 7Singh B,Shaha AR,Trivedi H,et al.Coexistent Hashimoto s thyroiditds with papillary thyroid carcinoma:impact on presentation,management,and outcome[J].Surgery,1999,126(6):1070-1076.
  • 8Machens A,Holzhausen HJ,Dralle H.Skip metastases in thyroid cancer leaping the central lymph node compartment[J].Arch Surg,2004,139(1):43-45.
  • 9高明.国内甲状腺癌的临床关注焦点与现状分析[J].中国肿瘤临床,2010,37(16):901-904. 被引量:19

二级参考文献25

  • 1钱碧云,何敏,董淑芬,王继芳,陈可欣.1981年至2001年天津市甲状腺癌的发病率和死亡率[J].中华内分泌代谢杂志,2005,21(5):432-434. 被引量:46
  • 2高明,李小龙,于洋,孙保存,李树玲,徐文贵.甲状腺癌的临床病理及PET-CT的诊断价值[J].中华耳鼻咽喉头颈外科杂志,2006,41(6):419-424. 被引量:25
  • 3高明,李小龙,高松源,孙保存,张连郁,巴图,李树玲.甲状腺乳头状癌组织学变型的临床生物学特性[J].中华普通外科杂志,2006,21(8):588-590. 被引量:14
  • 4Hunt JL, LiVolsi VA, Baloch ZW, et al. Microscopic papillary thyroid carcinoma compared with clinical carcinomas by loss of heterozygosity mutational profile[J]. Am J Surg Pathol, 2003, 27 (2): 159---166.
  • 5Kim TY, Kim WB, SongJY, et al. The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma[J]. Clin Endocrinol(Oxi), 2005, 63(5): 588-593.
  • 6Trovisco V, Soares P, Preto A, et al. Type and prevalence of BRAE mutations are dosely associated with papillary thyroid carcinoma histotype and patients age but not with tumour aggressiveness[J]. Virchows Arch, 2005, 446(6): 589--595.
  • 7Sedliarou I, Saenko V, Lantsov D, et al. The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcardnoma[J]. IntJ Oncol, 2004, 25(6): 1729--1735.
  • 8Sakorafas GH, Stafyla V, Bramis C, et al. Incidental parathyroidectomy during thyroid surgery: an underappreciated complication of thyroidectomy[J]. WorldJ Surg, 2005, 29(12): 1539-1543.
  • 9Sakorafas GH, GiotakisJ, Stafyla V. Papillary thyroid microcarcinoma: a surgical perspecdve[J]. Gancer Treat Rev, 2005, 31(6): 423-438.
  • 10Aheme ST,Smyth PC,Flavin RJ,et al.Geographical mapping of a multifocal thyroid tumour using genetic alteration analysis & miRNA profiling.Mol Cancer,2008,7:89 -93.

共引文献50

同被引文献11

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部